We next assessed the effects of vemurafenib treatment on TRIM16 protein stability using cycloheximide (CHX) chase studies, and found that vemurafenib markedly increased TRIM16 protein stability in melanoma cells (Fig. 5B and Supplementary Fig. 4). The gene discussed is TRIM16; the disease is melanoma.